Insilico – on a mission to accelerate senescence drug discovery and development by continuously inventing and deploying new AI technologies. …
Continue reading “Longevity senotherapeutics report: Insilico Medicine”
Cleara Biotech – on a mission to target cellular senescence to extend human healthspan at old age. Over the coming …
Continue reading “Longevity senotherapeutics report: Cleara Biotech”
Biomarkers for more stability in life – TAmiRNA is harnessing the power of microRNAs for the development of innovative diagnostic …
Continue reading “Longevity senotherapeutics report: TAmiRNA”
Strong academic pedigree is crafting senescence’s fate from rigorous science – suppression. Over the coming weeks, we will be bringing …
Continue reading “Longevity senotherapeutics report: Atropos Therapeutics”
A unique synergy of proprietary technologies and expertise is advancing compounds from discovery to preclinical efficacy. Over the coming weeks, …
Continue reading “Longevity senotherapeutics report: Rubedo Life Sciences”
Leveraging technology and information to address the damage created by the aging process itself. Over the coming weeks, we will …
Continue reading “Longevity senotherapeutics report: Oisín Biotechnologies”
Using senolytics to target a druggable pathway that plays a pivotal role in many age-related diseases. Over the coming weeks, …
Continue reading “Longevity senotherapeutics report: Rockfish Bio”
